EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Obeticholic Acid Inhibit Mitochondria Dysfunction Via Regulating ERK1/2‐DRP Pathway to Exert Protective Effect on Lipopolysaccharide‐Induced Myocardial Injury

Huijie Miao, Xiaomeng Tang, Yun Cui, Jingyi Shi, Xi Xiong, Chunxia Wang, Yucai Zhang iD

Advanced Biology · 2024

DOI: 10.1002/adbi.202300576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, 2024. Verfasst von Huijie Miao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200062, China. Hauptthemen laut MEDLINE: Lipopolysaccharides, Chenodeoxycholic Acid, Mice, Inbred C57BL, MAP Kinase Signaling System. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipal Education Commission-Gaofeng Clinical Medicine, Natural Science Foundation of Shanghai, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Farnesoid X receptor (FXR) plays critical regulatory roles in cardiovascular physiology/pathology. However, the role of FXR agonist obeticholic acid (OCA) in sepsis‐associated myocardial injury and underlying mechanisms remain unclear. C57BL/6J mice are treated with OCA before lipopolysaccharide (LPS) administration. The histopathology of the heart and assessment of FXR expression and mitochondria function are performed. To explore the underlying mechanisms, H9c2 cells, and primary cardiomyocytes are pre‐treated with OCA before LPS treatment, and extracellular signal‐regulated protein kinase (ERK) inhibitor PD98059 is used. LPS‐induced myocardial injury in mice is significantly improved by OCA pretreatment. Mechanistically, OCA pretreatment decreased reactive oxygen species (ROS) levels and blocked the loss of mitochondrial membrane potential (ΔΨm) in cardiomyocytes. The expression of glutathione peroxidase 1 (GPX1), superoxide dismutase 1 (SOD1), superoxide dismutase 2 (SOD2), and nuclear factor erythroid 2‐related factor 2 (NRF‐2) increased in the case of OCA pretreatment. In addition, OCA improved mitochondria respiratory chain with increasing Complex I expression and decreasing cytochrome C (Cyt‐C) diffusion. Moreover, OCA pretreatment inhibited LPS‐induced mitochondria dysfunction via suppressing ERK1/2‐DRP signaling pathway. FXR agonist OCA inhibits LPS‐induced mitochondria dysfunction via suppressing ERK1/2‐DRP signaling pathway to protect mice against LPS‐induced myocardial injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesChenodeoxycholic AcidMice, Inbred C57BLMAP Kinase Signaling SystemMyocytes, CardiacAnimalsMiceMaleReactive Oxygen SpeciesMitochondria, HeartMitochondriaCell LineReceptors, Cytoplasmic and NuclearReceptor, Farnesoid X-Activated

Stichwörter der Autor:innen

ERK1/2‐DRP signalingLPS‐associated myocardial injuryfarnesoid X receptormitochondria dysfunctionobeticholic acid

Substanzen

LipopolysaccharidesChenodeoxycholic AcidReactive Oxygen SpeciesReceptors, Cytoplasmic and NuclearReceptor, Farnesoid X-Activatedobeticholic acid

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200062, China.
  • Institute of Pediatric Critical Care, Shanghai Jiao Tong University School of Medicine, Shanghai, 200062, China.
  • Institute of Pediatric Infection, Immunity, and Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200062, China.
  • Clinical Research Unit, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200062, China.

ORCID-Profile: Yucai Zhang

Förderung

  • Shanghai Municipal Education Commission-Gaofeng Clinical Medicine
  • Natural Science Foundation of Shanghai
  • Science and Technology Commission of Shanghai Municipality
  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Miao, H., Tang, X., Cui, Y., Shi, J., Xiong, X., Wang, C., & Zhang, Y. (2024). Obeticholic Acid Inhibit Mitochondria Dysfunction Via Regulating ERK1/2‐DRP Pathway to Exert Protective Effect on Lipopolysaccharide‐Induced Myocardial Injury. Advanced Biology. https://doi.org/10.1002/adbi.202300576

Vancouver

Miao H, Tang X, Cui Y, Shi J, Xiong X, Wang C, et al. Obeticholic Acid Inhibit Mitochondria Dysfunction Via Regulating ERK1/2‐DRP Pathway to Exert Protective Effect on Lipopolysaccharide‐Induced Myocardial Injury. Advanced Biology. 2024. doi:10.1002/adbi.202300576

BibTeX
@article{Miao2024,
  author = {Miao, Huijie and Tang, Xiaomeng and Cui, Yun and Shi, Jingyi and Xiong, Xi and Wang, Chunxia and Zhang, Yucai},
  title = {Obeticholic Acid Inhibit Mitochondria Dysfunction Via Regulating ERK1/2‐DRP Pathway to Exert Protective Effect on Lipopolysaccharide‐Induced Myocardial Injury},
  journal = {Advanced Biology},
  year = {2024},
  doi = {10.1002/adbi.202300576}
}
Kostenlos starten →